Daclatasvir: a promising triple therapy for children with chronic hepatitis C

Lancet Infect Dis. 2013 Jan;13(1):17-8. doi: 10.1016/S1473-3099(12)70301-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Carbamates
  • Child
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Drug Resistance, Viral
  • Hepacivirus*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use*
  • Multicenter Studies as Topic
  • Pyrrolidines
  • Randomized Controlled Trials as Topic
  • Valine / analogs & derivatives

Substances

  • Carbamates
  • Imidazoles
  • Pyrrolidines
  • Valine
  • daclatasvir